An update on the status of HSP90 inhibitors in cancer clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An update on the status of HSP90 inhibitors in cancer clinical trials

Published:2024-08 Issue:4 Volume:29 Page:519-539
ISSN:1355-8145
Container-title:Cell Stress and Chaperones
language:en
Short-container-title:Cell Stress and Chaperones

Author:

Rastogi Shraddha,Joshi Abhinav,Sato Nahoko,Lee Sunmin,Lee Min-Jung,Trepel Jane B.,Neckers Len

Publisher

Elsevier BV

Reference140 articles.

1. Role of HSP90 in cancer;Birbo;Int J Mol Sci,2021

2. Heat shock proteins and HSF1 in cancer;Cyran;Front Oncol,2022

3. Maximizing the therapeutic potential of HSP90 inhibitors;Butler;Mol Cancer Res,2015

4. Post-translational modifications of Hsp90 and their contributions to chaperone regulation;Mollapour;Biochim Biophys Acta,2012

5. HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation;Kijima;Sci Rep,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Previously unrecognized and potentially consequential challenges facing Hsp90 inhibitors in cancer clinical trials;Cell Stress and Chaperones;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP